Clinical findings in recent studies have revealed various growth-promoting and survival pathways in the carcinogenesis of PCa, which implies the importance of understanding the alternative cellular pathways in disease progression and the interaction of these pathways with AR signaling. The gene discussed is AR; the disease is posterior cortical atrophy.